FDA Inspection 1100640 — UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program
The FDA completed an inspection of UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program on Jun 19, 2019 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 19, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Los Angeles, CA (United States)